Skip to main content

Compass Therapeutics, Inc.

CMPX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001738021

In the last 90 days, Compass Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 215 institutions reported holding it in 13F filings for Q2 2026, worth $363.4M in total; no superinvestor holds it.

Q2 2025 vs. Q1 2025

How the institutions holding Compass Therapeutics, Inc. changed between Q1 2025 and Q2 2025.

All holders in Q2 2025All holders in Q1 2025

13F holders of CMPX: Q1 2025 compared with Q2 2025
MeasureQ1 2025Q2 2025Change
Holders108103−5
Shares108.5M108.3M−215.0K (−0.2%)
Value$206.1M$281.5M+$75.4M (+36.6%)

New holders (19)

Institutions that held Compass Therapeutics, Inc. at the end of Q2 2025 but not at the end of Q1 2025.

Institutions new to CMPX in Q2 2025
InstitutionSharesValue% of portfolio
Suvretta Capital Management, LLC7,149,493$18.6M0.70%
Caption Management, LLC725,510$1.89M0.17%
DAFNA Capital Management LLC526,660$1.37M0.38%
Alps Advisors Inc74,597$194.0K0.00%
HRT Financial LP60,778$158.0K0.00%
AQR Capital Management LLC48,451$126.0K0.00%
Sig Brokerage, LP36,393$94.6K0.03%
XTX Topco Ltd32,415$84.3K0.00%
ADAR1 Capital Management, LLC25,000$65.0K0.01%
Squarepoint Ops LLC20,773$54.0K0.00%
Creative Planning11,484$29.9K0.00%
Victory Capital Management Inc10,488$27.3K0.00%
Raymond James Financial Inc4,894$12.7K0.00%
VSM Wealth Advisory, LLC3,000$7.80K0.00%
MCF Advisors LLC2,770$7.20K0.00%
Simplex Trading, LLC954$2.00K0.00%
Briaud Financial Planning, Inc700$1.00K0.00%
Skopos Labs, Inc.236$6140.00%
Rothschild Investment LLC120$3120.00%

Sold out (24)

Institutions that held Compass Therapeutics, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.